Real-World Data on Cabozantinib in Advanced Osteosarcoma and Ewing Sarcoma Patients: A Study from the Hellenic Group of Sarcoma and Rare Cancers

Advanced osteosarcomas (OSs) and Ewing sarcomas (ESs) tend to have poor prognosis with limited therapeutic options beyond first-line therapy. Aberrant angiogenesis and MET signaling play an important role in preclinical models. The anti-angiogenic drug cabozantinib was tested in a phase 2 trial of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kokkali, Stefania, Kyriazoglou, Anastasios, Mangou, Elpida, Economopoulou, Panagiota, Panousieris, Michail, Psyrri, Amanda, Ardavanis, Alexandros, Vassos, Nikolaos, Boukovinas, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918141/
https://www.ncbi.nlm.nih.gov/pubmed/36769769
http://dx.doi.org/10.3390/jcm12031119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918141/
https://www.ncbi.nlm.nih.gov/pubmed/36769769
http://dx.doi.org/10.3390/jcm12031119

Ejemplares similares